跳至主要内容
临床试验/IRCT20091114002709N56
IRCT20091114002709N56招募中3 期

The Effects of synbiotic supplementation in reducing of Chemotherapy-induced side effects in women with Breast Cancer

Iran University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Definitive diagnosis of breast cancer by oncologist and pathologist
  • Receiving one-day chemotherapy courses
  • Stage 1 to 3 of breast cancer (pre-metastatic stages)
  • History of complications following previous chemotherapy sessions
  • no history of gastrointestinal problems before breast cancer
  • at least one and at last two previous sessions of chemotherapy
  • Do not consuming probiotic dairy products or any foods containing probiotic or prebiotic compounds, or their supplements in the past two weeks.
  • Age 18 years and older
  • Willingness to cooperation

排除标准

  • Chronic diseases such as hypertension, coronary heart disease, history of stroke, liver failure (ALT and AST levels > 100 IU / L), renal failure (serum creatinine levels > 1.7 mg / dl), impaired cell count (WBC > 20,000 U / L, hemoglobin less than 10 mg / dl, platelets <15,000 / mcL or >400,000 / mcL) and gastrointestinal problems
  • Body mass index >30 kg / m2
  • History of tumor in other organs or metastasis to other organs
  • taking medicines or other treatments to reduce nausea (Except for the usual anti-nausea and vomiting medicines)
  • Severe gastrointestinal problems and complications during the study
  • Neutropenic patients
  • Consumption of probiotic dairy products or any foods containing probiotic or prebiotic compounds, or their supplements during the study
  • Recent infection or recent use of antibiotics in the past three months
  • Receiving radiation therapy and chemotherapy simultaneously
  • Not willing to continue cooperation

研究者

相似试验